T1	NC 0 5	Mujer
#1	Norm T1	mujer NCFS000
T2	SP 6 8	de
#2	Norm T2	de SPS00
T3	Z 9 11	56
#3	Norm T3	56 Z
T4	NC 12 16	años
#4	Norm T4	año NCMP000
T5	SP 17 19	de
#5	Norm T5	de SPS00
T6	NC 20 24	edad
#6	Norm T6	edad NCFS000
T7	Fc 24 25	,
#7	Norm T7	, Fc
T8	SP 26 29	con
#8	Norm T8	con SPS00
T9	NC 30 42	antecedentes
#9	Norm T9	antecedente NCMP000
T10	SP 43 45	de
#10	Norm T10	de SPS00
T11	NC 46 58	tuberculosis
#11	Norm T11	tuberculosis NCFN000
T12	AQ 59 67	pulmonar
#12	Norm T12	pulmonar AQ0CS0
T13	AQ 68 76	residual
#13	Norm T13	residual AQ0CS0
T14	Fc 76 77	,
#14	Norm T14	, Fc
T15	NC 78 87	carcinoma
#15	Norm T15	carcinoma NCMS000
T16	AQ 88 95	vesical
#16	Norm T16	vesical AQ0CS0
T17	VM 96 107	intervenido
#17	Norm T17	intervenir VMP00SM
T18	SP 108 110	en
#18	Norm T18	en SPS00
T19	Z 111 114	dos
#19	Norm T19	2 Z
T20	NC 115 124	ocasiones
#20	Norm T20	ocasión NCFP000
T21	CC 125 126	y
#21	Norm T21	y CC
T22	VM 127 134	tratado
#22	Norm T22	tratar VMP00SM
T23	RG 135 146	actualmente
#23	Norm T23	actualmente RG
T24	SP 147 150	con
#24	Norm T24	con SPS00
T25	NC 151 162	instilación
#25	Norm T25	instilación NCFS000
T26	AQ 163 168	local
#26	Norm T26	local AQ0CS0
T27	SP 169 171	de
#27	Norm T27	de SPS00
T28	NC 172 182	mitomicina
#28	Norm T28	mitomicina NC00000
T29	Fc 182 183	,
#29	Norm T29	, Fc
T30	NC 184 192	diabetes
#30	Norm T30	diabetes NCFN000
T31	AQ 193 201	mellitus
#31	Norm T31	mellitus AQ0CN0
T32	Fc 201 202	,
#32	Norm T32	, Fc
T33	NC 203 215	hipertensión
#33	Norm T33	hipertensión NCFS000
T34	AQ 216 224	arterial
#34	Norm T34	arterial AQ0CS0
T35	CC 225 226	e
#35	Norm T35	y CC
T36	NC 227 240	hiperuricemia
#36	Norm T36	hiperuricemia NCFS000
T37	Fc 240 241	,
#37	Norm T37	, Fc
T38	SP 242 247	desde
#38	Norm T38	desde SPS00
T39	VM 248 252	hace
#39	Norm T39	hacer VMIP3S0
T40	DI 253 255	un
#40	Norm T40	uno DI0MS0
T41	NC 256 259	mes
#41	Norm T41	mes NCMS000
T42	SP 260 262	en
#42	Norm T42	en SPS00
T43	NC 263 274	tratamiento
#43	Norm T43	tratamiento NCMS000
T44	SP 275 278	con
#44	Norm T44	con SPS00
T45	NC 279 289	alopurinol
#45	Norm T45	alopurinol NCMS000
T46	Fc 289 290	,
#46	Norm T46	, Fc
T47	VA 291 293	ha
#47	Norm T47	haber VAIP3S0
T48	VM 294 301	acudido
#48	Norm T48	acudir VMP00SM
T49	SP 302 303	a
#49	Norm T49	a SPS00
T50	NC 304 313	urgencias
#50	Norm T50	urgencia NCFP000
T51	SP 314 316	en
#51	Norm T51	en SPS00
T52	DI 317 323	varias
#52	Norm T52	varios DI0FP0
T53	NC 324 333	ocasiones
#53	Norm T53	ocasión NCFP000
T54	SP 334 335	a
#54	Norm T54	a SPS00
T55	DA 336 338	lo
#55	Norm T55	el DA0NS0
T56	AQ 339 344	largo
#56	Norm T56	largo AQ0MS0
T57	SP 345 347	de
#57	Norm T57	de SPS00
T58	Z 348 350	10
#58	Norm T58	10 Z
T59	NC 351 355	días
#59	Norm T59	día NCMP000
T60	Fc 355 356	,
#60	Norm T60	, Fc
T61	SP 357 360	por
#61	Norm T61	por SPS00
T62	NC 361 367	crisis
#62	Norm T62	crisis NCFN000
T63	SP 368 370	de
#63	Norm T63	de SPS00
T64	NC 371 377	disnea
#64	Norm T64	disnea NCFS000
T65	AQ 378 383	junto
#65	Norm T65	junto AQ0MS0
T66	SP 384 387	con
#66	Norm T66	con SPS00
T67	NC 388 396	erupción
#67	Norm T67	erupción NCFS000
T68	AQ 397 404	cutánea
#68	Norm T68	cutáneo AQ0FS0
T69	CC 405 406	y
#69	Norm T69	y CC
T70	P0 407 409	se
#70	Norm T70	se P00CN000
T71	VM 410 412	ha
#71	Norm T71	haber VMIP3S0
T72	VM 413 420	tratada
#72	Norm T72	tratar VMP00SF
T73	SP 421 426	desde
#73	Norm T73	desde SPS00
T74	DA 427 429	el
#74	Norm T74	el DA0MS0
T75	NC 430 436	inicio
#75	Norm T75	inicio NCMS000
T76	SP 437 440	del
#76	Norm T76	de+el SPS00+DA0MS0
T77	NC 441 447	cuadro
#77	Norm T77	cuadro NCMS000
T78	SP 448 451	con
#78	Norm T78	con SPS00
T79	NC 452 463	corticoides
#79	Norm T79	corticoide NCMP000
T80	SP 464 465	a
#80	Norm T80	a SPS00
T81	NC 466 471	dosis
#81	Norm T81	dosis NCFN000
T82	AQ 472 477	altas
#82	Norm T82	alto AQ0FP0
T83	Fc 477 478	,
#83	Norm T83	, Fc
T84	AQ 479 495	antihistamínicos
#84	Norm T84	antihistamínico AQ0MP0
T85	CC 496 497	y
#85	Norm T85	y CC
T86	NC 498 512	aerosolterapia
#86	Norm T86	aerosolterapia NCFS000
T87	Fp 512 513	.
#87	Norm T87	. Fp
T88	VM 514 521	Ingresó
#88	Norm T88	ingresar VMIS3S0
T89	SP 522 524	en
#89	Norm T89	en SPS00
T90	NC 525 528	UCI
#90	Norm T90	UCI NC00000
T91	SP 529 532	con
#91	Norm T91	con SPS00
T92	NC 533 541	sospecha
#92	Norm T92	sospecha NCFS000
T93	SP 542 544	de
#93	Norm T93	de SPS00
T94	NC 545 548	NET
#94	Norm T94	NET NC00000
T95	Fc 548 549	,
#95	Norm T95	, Fc
T96	VM 550 561	presentando
#96	Norm T96	presentar VMG0000
T97	NC 562 570	erupción
#97	Norm T97	erupción NCFS000
T98	AQ 571 582	eritematosa
#98	Norm T98	eritematoso AQ0FS0
T99	AQ 583 597	maculopapulosa
#99	Norm T99	maculopapuloso AQ0FS0
T100	CC 598 599	y
#100	Norm T100	y CC
T101	AQ 600 609	ampollosa
#101	Norm T101	ampolloso AQ0FS0
T102	SP 610 612	en
#102	Norm T102	en SPS00
T103	DA 613 615	el
#103	Norm T103	el DA0MS0
T104	Z 616 619	70%
#104	Norm T104	70% Z
T105	SP 620 622	de
#105	Norm T105	de SPS00
T106	DA 623 625	la
#106	Norm T106	el DA0FS0
T107	NC 626 636	superficie
#107	Norm T107	superficie NCFS000
T108	AQ 637 645	corporal
#108	Norm T108	corporal AQ0CS0
T109	Fc 645 646	,
#109	Norm T109	, Fc
T110	NC 647 652	signo
#110	Norm T110	signo NCMS000
T111	SP 653 655	de
#111	Norm T111	de SPS00
T112	NP 656 664	Nikolsky
#112	Norm T112	nikolsky NP00000
T113	AQ 665 673	positivo
#113	Norm T113	positivo AQ0MS0
T114	Fx 673 674	;
#114	Norm T114	; Fx
T115	NC 675 688	insuficiencia
#115	Norm T115	insuficiencia NCFS000
T116	AQ 689 701	respiratoria
#116	Norm T116	respiratorio AQ0FS0
T117	NC 702 706	tipo
#117	Norm T117	tipo NCMS000
T118	NC 707 708	I
#118	Norm T118	I NC00000
T119	Fc 708 709	,
#119	Norm T119	, Fc
T120	NC 710 723	insuficiencia
#120	Norm T120	insuficiencia NCFS000
T121	AQ 724 729	renal
#121	Norm T121	renal AQ0CS0
T122	AQ 730 734	leve
#122	Norm T122	leve AQ0CS0
T123	CC 735 736	y
#123	Norm T123	y CC
T124	NC 737 746	tendencia
#124	Norm T124	tendencia NCFS000
T125	SP 747 748	a
#125	Norm T125	a SPS00
T126	NC 749 760	hipotensión
#126	Norm T126	hipotensión NCFS000
T127	Fp 760 761	.
#127	Norm T127	. Fp
T128	P0 762 764	Se
#128	Norm T128	se P00CN000
T129	VM 765 771	inició
#129	Norm T129	iniciar VMIS3S0
T130	NC 772 783	tratamiento
#130	Norm T130	tratamiento NCMS000
T131	SP 784 786	de
#131	Norm T131	de SPS00
T132	NC 787 794	soporte
#132	Norm T132	soporte NCMS000
T133	CC 795 796	y
#133	Norm T133	y CC
T134	NC 797 809	ciclosporina
#134	Norm T134	ciclosporina NCFS000
T135	NC 810 812	A.
#135	Norm T135	A. NC00000
T136	NP 813 815	La
#136	Norm T136	la NP00000
T137	NC 816 824	paciente
#137	Norm T137	paciente NCCS000
T138	VA 825 827	ha
#138	Norm T138	haber VAIP3S0
T139	VM 828 840	evolucionado
#139	Norm T139	evolucionar VMP00SM
T140	RG 841 855	favorablemente
#140	Norm T140	favorablemente RG
T141	Fc 855 856	,
#141	Norm T141	, Fc
T142	P0 857 859	se
#142	Norm T142	se P00CN000
T143	VA 860 863	han
#143	Norm T143	haber VAIP3P0
T144	VM 864 877	reepitelizado
#144	Norm T144	reepitelizar VMP00SM
T145	RG 878 891	completamente
#145	Norm T145	completamente RG
T146	DA 892 895	las
#146	Norm T146	el DA0FP0
T147	NC 896 904	lesiones
#147	Norm T147	lesión NCFP000
T148	AQ 905 913	cutáneas
#148	Norm T148	cutáneo AQ0FP0
T149	SP 914 915	a
#149	Norm T149	a SPS00
T150	DA 916 919	los
#150	Norm T150	el DA0MP0
T151	Z 920 922	21
#151	Norm T151	21 Z
T152	NC 923 927	días
#152	Norm T152	día NCMP000
T153	SP 928 930	de
#153	Norm T153	de SPS00
T154	DP 931 933	su
#154	Norm T154	su DP3CS0
T155	NC 934 941	ingreso
#155	Norm T155	ingreso NCMS000
T156	SP 942 944	en
#156	Norm T156	en SPS00
T157	NC 945 948	UCI
#157	Norm T157	UCI NC00000
T158	Fc 948 949	,
#158	Norm T158	, Fc
T159	CC 950 951	y
#159	Norm T159	y CC
T160	P0 952 954	se
#160	Norm T160	se P00CN000
T161	VA 955 957	ha
#161	Norm T161	haber VAIP3S0
T162	VM 958 964	podido
#162	Norm T162	poder VMP00SM
T163	VM 965 970	darle
#163	Norm T163	dar+le VMN0000+PP3CSD00
T164	DA 971 973	el
#164	Norm T164	el DA0MS0
T165	AQ 974 978	alta
#165	Norm T165	alto AQ0FS0
T166	SP 979 980	a
#166	Norm T166	a SPS00
T167	NC 981 987	planta
#167	Norm T167	planta NCFS000
T168	Fp 987 988	.
#168	Norm T168	. Fp
